Our goals were to (1) assess dAMPH-mediated effects on mood in PD, (2) localize dAMPH-induced DA release, and (3) determine the relationship between baseline D2-R availability and dAMPH-induced effects on mood. Here, DRD2 is linked to Parkinson disease.